Literature DB >> 31926319

De-labeling penicillin-allergic children in outpatients using telemedicine: Potential to replicate in primary care.

Hilary I Allen1, Marta Vazquez-Ortiz2, Andrew W Murphy3, Edina M Moylett4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31926319     DOI： 10.1016/j.jaip.2019.12.034

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  5 in total

1.  Penicillin Allergy Delabeling: A Multidisciplinary Opportunity.

Authors:  Mary L Staicu; David Vyles; Erica S Shenoy; Cosby A Stone; Taylor Banks; Kristin S Alvarez; Kimberly G Blumenthal
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10

Review 2.  Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations.

Authors:  Karen M Anstey; Lulu Tsao; Iris M Otani
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 8.667

3.  Simplifying the drug provocation test in non-immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit.

Authors:  Giulia Liccioli; Mattia Giovannini; Jean-Christoph Caubet; Simona Barni; Lucrezia Sarti; Paola Parronchi; Manuela Capone; Leonardo Tomei; Francesca Mori
Journal:  Pediatr Allergy Immunol       Date:  2022-06       Impact factor: 5.464

Review 4. 

Authors:  Stephanie Dramburg; Uso Walter; Sven Becker; Ingrid Casper; Stefani Röseler; Astrid Schareina; Holger Wrede; Ludger Klimek
Journal:  Allergo J       Date:  2021-06-25

Review 5.  The Potential of Clinical Decision Support Systems for Prevention, Diagnosis, and Monitoring of Allergic Diseases.

Authors:  Stephanie Dramburg; María Marchante Fernández; Ekaterina Potapova; Paolo Maria Matricardi
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.